News·October 14, 2026 at 6:41 AM EDT·1 source
GSK could cut more than 1,200 jobs in Belgium
GSK -0.9%
GSK · last 30 trading days+9.7% since the news
News
What happened
- GSK could make up to 1,217 workers redundant at its sites in Belgium.
- The cuts are part of a cost-cutting initiative announced by CEO Luke Miels in July.
Potential job cuts
1,217
Why it matters
The proposed reductions are relevant to healthcare professionals tracking GSK’s cost base, workforce strategy and operations in Belgium.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 12GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania
- First reported by Endpoints NewsOct 14GSK could cut more than 1,200 jobs in Belgium
Who is involved
GSK could cut more than 1,200 jobs in BelgiumGSKGSKLuke Miels
CompanyPerson
Sources (1)
- Endpoints NewsOct 14GSK could cut more than 1,200 jobs in Belgium
Related
- Oct 21 · GSK gets FDA approval for hepatitis B drug that offers functional cure
- Oct 21 · CSL hires ViiV CEO Deborah Waterhouse after three decades at GSK
- Oct 19 · #ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and more
- Oct 12 · GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.